Faecal microbiota signature for pancreatic cancer

Patent number:

WO2023/052486

Comunidad de Madrid.svg
No items found.

The CNIO has developed a method for early detection of pancreatic cancer. The inventors have found a method for early diagnosing pancreatic cancer based on a faecal microbiota signature with high specificity for pancreatic cancer.

Countries:
Spain
Regions:
Community of Madrid
Centers:
CNIO, FUNDACION CNIO
Other entities:
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The method of the invention is a sensitive, specific and non-invasive method for an early detection of pancreatic cancer, in particular Pancreatic Ductal Adenocarcinoma (PDAC) that could therefore improve survival outcomes. The present invention refers to a method for diagnosing pancreatic cancer in a subject comprising determining the abundance of several Microbiome species in a faecal sample from said subject, as well as to a kit and its use for the diagnosis of pancreatic cancer.

Comments

Other related patents

Health

Device for optical measurements of diffractive biosensitive materials

Countries
Spain
Know more
Health

Use of TRF1 inhibitors for the treatment or prevention of brain cancer

Countries
Spain
Know more
Health

COMPOSITIONS FOR TREATING DISEASES RELATED TO L YSOME DISORDERS

Countries
Spain
Know more
Get back to patents directory